BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17240494)

  • 1. The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.
    Rojas Caraballo J; Delgado G; Rodriguez R; Patarroyo MA
    Vaccine; 2007 May; 25(18):3713-21. PubMed ID: 17240494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.
    Giraldo MA; Arevalo-Pinzon G; Rojas-Caraballo J; Mongui A; Rodriguez R; Patarroyo MA
    Vaccine; 2009 Dec; 28(1):7-13. PubMed ID: 19782110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
    Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
    Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response.
    Bueno LL; Fujiwara RT; Soares IS; Braga EM
    Vaccine; 2008 Feb; 26(9):1204-13. PubMed ID: 18242795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
    Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
    Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
    Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of the Plasmodium vivax reticulocyte binding-like proteins (PvRBPs).
    Li J; Han ET
    Biochem Biophys Res Commun; 2012 Sep; 426(1):1-6. PubMed ID: 22925889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.
    Arévalo-Herrera M; Roggero MA; Gonzalez JM; Vergara J; Corradin G; López JA; Herrera S
    Ann Trop Med Parasitol; 1998 Jul; 92(5):539-51. PubMed ID: 9797827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity.
    Gupta ED; Anand G; Singh H; Chaddha K; Bharti PK; Singh N; Sharma YD; Gaur D
    J Infect Dis; 2017 May; 215(10):1558-1568. PubMed ID: 28379500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
    Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys.
    Barrero CA; Delgado G; Sierra AY; Silva Y; Parra-Lopez C; Patarroyo MA
    Vaccine; 2005 Jul; 23(31):4048-53. PubMed ID: 15893858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in Plasmodium vivax by Protein Microarray Based Immunoscreening.
    Han JH; Li J; Wang B; Lee SK; Nyunt MH; Na S; Park JH; Han ET
    Korean J Parasitol; 2015 Aug; 53(4):403-11. PubMed ID: 26323838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
    Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
    Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
    Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.
    Cheng Y; Wang B; Sattabongkot J; Lim CS; Tsuboi T; Han ET
    Parasitol Res; 2014 Jul; 113(7):2559-68. PubMed ID: 24764159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region.
    Yadava A; Hall CE; Sullivan JS; Nace D; Williams T; Collins WE; Ockenhouse CF; Barnwell JW
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3268. PubMed ID: 25329054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys.
    Castellanos A; Arévalo-Herrera M; Restrepo N; Gulloso L; Corradin G; Herrera S
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):411-6. PubMed ID: 17568948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.